The Dognostica directory board has a strong track record in bringing medical devices to the market. the team has developed patent ways to address the difficulty which have prevented others from turning dogs' noses into reliable disease screening tools. The company’s two Co-Founders have more than 25 years of experiences, in handling dogs, working with world-leading security units dealing with explosives and drugs.
Sagi Barkay- CEOElectronic engineer with MBA from Ben Gurion University, 25 years of experience as a project manager for multidisciplinary high budget (~$200M) technology projects.
managing about 100 technicians and engineers.
Tamir Goren - Co-founderHas more than 20 years professional experience in the Israeli security K-9 (dog unit) gained in the military and police services as a trainer and team commander. He has been working at the Hebrew University in charge of its canine unit.
Golan Nir - Co FounderBegan his carrier in 1994 in the Canine unit in the Israeli army where he operated and extensively worked and trained dogs to help fight terrorism, find and rescue civilians and soldiers in different operational activities. More recently he has focused on applying the expertise he gained in the defence industry into developing the technology behind the Dognostica system.
Prof. Mickey Scheinowitz DirectorPhD in Cardiovascular Physiology
Chairman of the Department of Biomedical Engineering and the founder and Director of Biomedical Technology Innovation Program at Tel-Aviv university. Prof. Scheinowitz serves also as the Chief Scientist at Aerotel Ltd. He graduated from the Merage Medical Device Program and the Directorship program at Recanati, Tal Aviv University
Ella Barkay UK-ResearchMSc degree in medical sciences from the Technion. Experienced as a lab manager at the Weizmann Institute of Science –a leading research institute. Experienced as a medical representative in an international pharmaceutical company, and Years of experience in high tech employee's recruitment
Dr Adam Eshel Clinical TrialM.D at Meir Hospital.
Hold a European doctor's license. GCP certified and experienced in clinical trials.
works with business and private clients.
Intensive worker and meeting deadlines and targets
Dr Marcus Gould - Regulatory AdvisorPHD Biochemistry, Oxford University, has established multi-national companies encompassing all aspects of CE mark, FDA, and Human Tissue Authority (HTA) activities. Marcus’s experience includes both pre-market and post-market activities, and he devises and implements regulatory strategies for CE Marking, US FDA applications and HTA submissions.
Marcus has designed, implemented and maintained Quality Management Systems for ISO 9001, ISO 13485, ISO 17025, ISO 15189, and HTA certification. He is
Dr Asher Holzer - ChairmanPhD in Applied Physics from the Hebrew University.Physicist by training. Serial entrepreneur with >30 years of senior leadership experience in the medical device industry, transitioning emerging technologies from research to clinical care, raising venture capital funds, taking companies public. Has served as director with both start-up and publicly traded companies including: InspireMD, TheraCoat, BioSig (USA), Magnetecs (USA), Adar, 2to3D, OSHIL., S.P. Market Windows and others
Roy Yam- Software developmenAn experienced Algorithms and Digital Signal Processing (DSP) engineer. Roy worked in the R&D departments of several world leading high tech companies and gained experience and knowledge in many subjects such as embedded programming, digital communication and audio processing. Roy has also worked as an Intellectual Property Manager in the hi-tech field.
Amir Dr Amir Onn - Advisory boardDirector of the Oncology Lung Department at Sheba Hospital in Ramat Gan, is poised to join the team as an Advisor once funding is secured. Sheba Hospital is the largest hospital in Israel. The hospital partners with the Weizmann Institute and runs 25% of all medical research conducted in Israel
Peter A. Woolsey PR & FundraisingA socially focused multinational entrepreneur who launched a wind farm in the Isle of Skye, Scotland. Taking an active part in the partnership between Manchester University and the Estonian plasma assisted combustion technology project.
Ex-Vice president INSEAD UK alumni, current Estonian alumni representative and Rotary foundation fellow. Peter has an MBA from INSEAD, and he studied Economics at Manchester University.